| Literature DB >> 25852770 |
Afaf El-Ansary1, Ramesa Shafi Bhat2, Sooad Al-Daihan2, Abeer M Al Dbass2.
Abstract
HYPOTHESIS: A healthy gut with normal intestinal microflora is completely disrupted by oral antibiotics. The byproducts of harmful gut bacteria can interfere with brain development and may contribute to autism. Strategies to improve the gut microflora profile through dietary modification may help to alleviate gut disorders in autistic patients.Entities:
Keywords: Ampicillin; Autism; Dietary regimens; Gut microbiota; Neurotoxicity; Propionic acid
Year: 2015 PMID: 25852770 PMCID: PMC4387705 DOI: 10.1186/s13099-015-0054-4
Source DB: PubMed Journal: Gut Pathog ISSN: 1757-4749 Impact factor: 4.181
Descriptive changes in the fecal flora immediately after an orogastric dose of ampicillin (50 mg/kg for three weeks)
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| + | + | + | + | + |
|
| + | - | - | - | - |
|
| + | + | + | + | + |
|
| - | - | + | + | - |
|
| - | - | - | - | - |
|
| - | - | - | - | - |
|
| - | + | + | + | + |
|
| - | + | + | + | + |
|
| - | + | - | + | - |
|
| - | - | + | + | - |
|
| - | - | - | + | - |
Descriptive changes in the fecal flora six weeks after orogastric ampicillin (50 mg/kg for three weeks)
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| + | + | + | + | + |
|
| + | - | - | - | - |
|
| + | + | + | + | + |
|
| - | + | - | + | + |
|
| - | - | - | - | - |
|
| - | - | - | - | - |
|
| - | + | - | + | + |
|
| - | + | + | + | + |
|
| - | - | - | - | - |
|
| - | - | - | - | - |
|
| - | - | - | + | - |
|
| - | - | - | + | + |
|
| - | - | - | + | - |
Mean ± S.D. of all the measured parameters in PPA-treated, ampicillin-treated and animals fed various diets compared to control
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| Glutathione (μg/ml) | Control | 10 | 67.02 ± 14.29 | 100.00 | 0.001 | ||
| Pro-acid | 10 | 53.38 ± 11.98 | 79.65 | 0.033 | |||
| Ampicillin (A) | 10 | 44.35 ± 9.97 | 66.18 | 0.001 | 0.084 | ||
| A + CHO | 10 | 43.89 ± 6.51 | 65.49 | 0.001 | 0.041 | ||
| A + Protein | 10 | 72.46 ± 14.94 | 108.12 | 0.416 | 0.006 | ||
| A + Oil | 9 | 52.33 ± 16.34 | 78.08 | 0.052 | 0.874 | ||
| Lipid peroxides (MD μmoles/ml) | Control | 10 | 0.057 ± 0.005 | 100.00 | 0.001 | ||
| Pro-acid | 10 | 0.118 ± 0.037 | 206.48 | 0.001 | |||
| Ampicillin | 10 | 0.070 ± 0.010 | 122.94 | 0.002 | 0.003 | ||
| A + CHO | 10 | 0.067 ± 0.022 | 116.46 | 0.204 | 0.002 | ||
| A + Protein | 10 | 0.119 ± 0.017 | 208.41 | 0.001 | 0.933 | ||
| A + Oil | 9 | 0.157 ± 0.031 | 274.43 | 0.001 | 0.025 | ||
| Glutathione S-transferase activity (U/ml) | Control | 10 | 227.06 ± 50.39 | 100.00 | 0.011 | ||
| Pro-acid | 10 | 190.62 ± 28.97 | 83.95 | 0.063 | |||
| Ampicillin | 10 | 256.14 ± 21.94 | 112.81 | 0.120 | 0.001 | ||
| A + CHO | 10 | 235.17 ± 50.96 | 103.57 | 0.725 | 0.027 | ||
| A + Protein | 10 | 245.27 ± 45.71 | 108.02 | 0.408 | 0.005 | ||
| A + Oil | 9 | 240.74 ± 26.27 | 106.02 | 0.476 | 0.001 | ||
| Catalase activity (U/dL) | Control | 10 | 6.59 ± 1.89 | 100.00 | 0.001 | ||
| Pro-acid | 10 | 9.31 ± 3.48 | 141.31 | 0.047 | |||
| Ampicillin | 10 | 7.53 ± 2.09 | 114.28 | 0.306 | 0.186 | ||
| A + CHO | 10 | 4.80 ± 3.03 | 72.84 | 0.130 | 0.006 | ||
| A + Protein | 10 | 10.56 ± 3.77 | 160.24 | 0.011 | 0.452 | ||
| A + Oil | 9 | 8.91 ± 2.41 | 135.15 | 0.032 | 0.774 | ||
| Potassium (mmol/L) | Control | 10 | 10.10 ± 1.97 | 100.00 | 0.001 | ||
| Pro-acid | 10 | 8.48 ± 1.81 | 83.95 | 0.072 | |||
| Ampicillin | 10 | 9.18 ± 2.26 | 90.84 | 0.342 | 0.456 | ||
| A + CHO | 10 | 15.19 ± 3.34 | 150.34 | 0.001 | 0.001 | ||
| A + Protein | 10 | 13.74 ± 1.89 | 136.00 | 0.001 | 0.001 | ||
| A + Oil | 9 | 15.31 ± 3.55 | 151.61 | 0.001 | 0.001 | ||
| Creatine kinase (U/L) | Control | 8 | 3900.01 ± 495.26 | 100.00 | 0.001 | ||
| Pro-acid | 10 | 3948.36 ± 422.41 | 101.24 | 0.826 | |||
| Ampicillin | 9 | 4138.42 ± 353.99 | 106.11 | 0.267 | 0.306 | ||
| A + CH | 9 | 3824.58 ± 618.43 | 98.07 | 0.787 | 0.614 | ||
| A + Protein | 7 | 3945.15 ± 159.99 | 101.16 | 0.813 | 0.983 | ||
| A + Oil | 7 | 3062.79 ± 257.84 | 78.53 | 0.002 | 0.001 | ||
| Lactate dehydrogenase (μmoles) | Control | 10 | 1842.16 ± 420.30 | 100.00 | 0.001 | ||
| Pro-acid | 10 | 2525.06 ± 322.42 | 137.07 | 0.001 | |||
| Ampicillin | 10 | 2547.80 ± 232.25 | 138.30 | 0.001 | 0.858 | ||
| A + CH | 10 | 2773.58 ± 208.62 | 150.56 | 0.001 | 0.056 | ||
| A + Protein | 8 | 2512.36 ± 505.38 | 136.38 | 0.007 | 0.949 | ||
| A + Oil | 6 | 2564.08 ± 381.26 | 139.19 | 0.004 | 0.830 |
P value between control group and other groups.
P value between Pro-acid group and other groups.
P value between all groups.
N.B. Variations in the numbers of investigated samples in each group are due to the insufficiency of certain samples or the death of animals during the experimental period (e.g., animals fed a high-lipid diet).
Pearson’s correlations between the measured parameters
|
|
|
| |
|---|---|---|---|
| Lipid peroxides vs. Catalase activity | 0.329* | 0.011 | Pa |
| Lipid peroxides vs. Potassium | 0.256* | 0.050 | Pa |
| Potassium vs. Glutathione S-transferase activity | 0.264* | 0.043 | Pa |
| Potassium vs. Creatine kinase | −0.340* | 0.016 | Nb |
Correlation is significant at the 0.01 level.
Correlation is significant at the 0.05 level.
Positive correlation.
Negative correlation.
Figure 1Pearson’s correlations between eight measured parameters. A. catalase activity verses lipid peroxides, B. potassium verses lipid peroxides, C. potassium verses glutathione-s-transferases, D. creatine kinase verses potassium.
ROC curve of all parameters in all groups
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Glutathione (ug/ml) | Pro-acid | 0.504 | 56.755 | 60.0% | 60.2% |
| Ampicillin | 0.731 | 54.345 | 90.0% | 55.1% | |
| A + CHO | 0.784 | 45.800 | 80.0% | 77.6% | |
| A + Protein | 0.834 | 63.880 | 80.0% | 83.7% | |
| A + Oil | 0.583 | 42.130 | 44.4% | 82.0% | |
| Lipid peroxides (MD μmoles/ml) | Pro-acid | 0.695 | 0.068 | 100.0% | 36.7% |
| Ampicillin | 0.691 | 0.083 | 100.0% | 57.1% | |
| A + CHO | 0.695 | 0.089 | 100.0% | 51.0% | |
| A + Protein | 0.734 | 0.089 | 100.0% | 69.4% | |
| A + Oil | 0.931 | 0.135 | 88.9% | 88.0% | |
| Glutathione S-transferase activity (U/ml) | Pro-acid | 0.846 | 216.145 | 90.0% | 75.5% |
| Ampicillin | 0.716 | 221.350 | 100.0% | 44.9% | |
| A + CHO | 0.502 | 247.350 | 50.0% | 65.3% | |
| A + Protein | 0.578 | 278.645 | 30.0% | 89.8% | |
| A + Oil | 0.560 | 216.145 | 88.9% | 40.0% | |
| Catalase activity (U/dL) | Pro-acid | 0.612 | 9.360 | 50.0% | 75.5% |
| Ampicillin | 0.528 | 9.360 | 90.0% | 32.7% | |
| A + CHO | 0.813 | 5.000 | 70.0% | 89.8% | |
| A + Protein | 0.740 | 10.680 | 50.0% | 89.8% | |
| A + Oil | 0.660 | 7.440 | 88.9% | 54.0% | |
| Potassium (mmol/L) | Pro-acid | 0.820 | 10.485 | 100.0% | 69.4% |
| Ampicillin | 0.806 | 8.890 | 80.0% | 83.7% | |
| A + CHO | 0.804 | 12.790 | 90.0% | 67.3% | |
| A + Protein | 0.711 | 10.780 | 100.0% | 53.1% | |
| A + Oil | 0.802 | 11.145 | 100.0% | 54.0% | |
| Creatine kinase (U/L) | Pro-acid | 0.580 | 3315.665 | 100.0% | 25.0% |
| Ampicillin | 0.732 | 4155.140 | 66.7% | 78.0% | |
| A + CHO | 0.518 | 4065.610 | 66.7% | 58.5% | |
| A + Protein | 0.515 | 4122.180 | 100.0% | 44.2% | |
| A + Oil | 0.947 | 3522.195 | 100.0% | 83.7% | |
| Lactate dehydrogenase (μmoles) | Pro-acid | 0.551 | 2033.600 | 100.0% | 22.7% |
| Ampicillin | 0.539 | 2295.660 | 90.0% | 36.4% | |
| A + CH | 0.797 | 2435.740 | 100.0% | 52.3% | |
| A + Protein | 0.543 | 2589.005 | 75.0% | 50.0% | |
| A + Oil | 0.628 | 2803.150 | 50.0% | 85.4% |
Multiple regression using the Stepwise method with lipid peroxides (MD μmoles/ml) as a dependent variable
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
|
| ||||
| reatine kinase (U/L) | −0.339 | 0.01 | 0.251 | 6.350 | 0.001 |
| Catalase activity (U/dL) | 0.314 | 0.017 | |||
| Lactate dehydrogenase (μmoles) | 0.304 | 0.02 | |||